LPTI Stock Overview

Develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States. More details

LPTI fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Latest financial reports are more than a year old

Does not have a meaningful market cap ($23)

High level of non-cash earnings

My Notes

Capture your thoughts, links and company narrative

Longport, Inc. Competitors

Genocea Biosciences

OTCPK:GNCA.Q

US$5.9k

Innovation Pharmaceuticals

OTCPK:IPIX

US$52.9k

Molecular Templates

OTCPK:MTEM

US$197.5k

Histogen

OTCPK:HSTO.Q

US$118.3k

Price History & Performance

Summary of share price highs, lows and changes for Longport
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.0001
52 Week Low	US$0.000001
Beta	0
1 Month Change	-99.00%
3 Month Change	-99.00%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	-99.90%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	LPTI	US Biotechs	US Market
7D	-99.0%	-0.1%	-0.5%
1Y	n/a	-6.4%	23.2%

Return vs Industry: Insufficient data to determine how LPTI performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how LPTI performed against the US Market.

Price Volatility

Is LPTI's price volatile compared to industry and market?
LPTI volatility
LPTI Average Weekly Movement	n/a
Biotechs Industry Average Movement	11.1%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.6%
10% least volatile stocks in US Market	3.2%

Stable Share Price: LPTI's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine LPTI's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1993	n/a	Michael Boyd	www.longportinc.com

Longport, Inc. develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States. It offers EPISCAN I-200, a high frequency ultrasound imaging system that utilizes ultrasound at frequencies between 20 and 50MHz to image the skin and underlying soft tissue. The company’s products are used in wound assessment, wound prevention, clinical dermatology, and aesthetics/plastics, as well as in various other applications, including burn assessment, superficial musculoskeletal imaging, and veterinary applications.

Longport, Inc. Fundamentals Summary

How do Longport's earnings and revenue compare to its market cap?
LPTI fundamental statistics
Market cap	US$23.00
Earnings (TTM)	-US$1.31m
Revenue (TTM)	US$1.19m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is LPTI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LPTI income statement (TTM)
Revenue	US$1.19m
Cost of Revenue	US$558.65k
Gross Profit	US$627.85k
Other Expenses	US$1.94m
Earnings	-US$1.31m

Last Reported Earnings

Sep 30, 2005

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did LPTI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/10 00:02
End of Day Share Price	2025/01/06 00:00
Earnings	2005/09/30
Annual Earnings	2004/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Longport, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution